MAXIM PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-08-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, 10-Q, 2000-08-14
Next: DEUTSCHE MORTGAGE & ASSET RECEIVING CORP, 424B5, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                     106,033,260
<SECURITIES>                                91,719,597
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           201,739,854
<PP&E>                                       5,302,822
<DEPRECIATION>                             (1,857,281)
<TOTAL-ASSETS>                             243,435,875
<CURRENT-LIABILITIES>                       15,906,848
<BONDS>                                        796,325
                                0
                                          0
<COMMON>                                        22,740
<OTHER-SE>                                 226,709,962
<TOTAL-LIABILITY-AND-EQUITY>               243,435,875
<SALES>                                              0
<TOTAL-REVENUES>                               427,750
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            27,707,661
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              51,503
<INCOME-PRETAX>                           (73,327,546)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (73,327,546)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (73,327,546)
<EPS-BASIC>                                     (4.48)
<EPS-DILUTED>                                   (4.48)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission